14. Alpha-Synuclein
Alpha-synuclein is most commonly associated with Parkinson’s disease, but research indicates it is also elevated in Alzheimer’s patients. Measuring alpha-synuclein in the cerebrospinal fluid may assist in distinguishing Alzheimer’s from other neurodegenerative conditions, especially when combined with additional biomarkers. This differentiation is crucial for targeted treatment approaches. For a deeper exploration, see Acta Neuropathologica.